Evidence-based, high-impact
software as medicine.
Click’s platform can target any disease, symptom or side effect with an underlying neurological or behavioral component, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases.
CT-152
Rejoyn
Indication
Major Depressive Disorder (MDD)
Collaborator
Phase
Launch- AspyreRx
AspyreRx
AspyreRx™
Indication
Type 2 Diabetes
Collaborator
Phase
FDA Cleared - CT-132
CT-132
Indication
Episodic Migraine
Collaborator
Phase
Regulatory Review - CT-155
CT-155
Indication
Schizophrenia
Collaborator
Phase
Phase 3: Pivotal - CT-156
CT-156
Indication
Schizophrenia
Collaborator
Phase
Phase 2: Dev/Pilot - CT-102
CT-102
Indication
Opioid Use Disorder (OUD)
Collaborator
Phase
Phase 2: Dev/Pilot - CT-133
CT-133
Indication
Multiple Sclerosis (MS)
Collaborator
Phase
Phase 1: Discovery - CT-171
CT-171
Indication
Atopic Dermatitis
Collaborator
Phase
Phase 1: Discovery - CT-181
CT-181
Indication
Obesity
Collaborator
Phase
Phase 1: Discovery - CT-191
CT-191
Indication
Oncology
Collaborator
Phase
Phase 1: Discovery - CT-141
CT-141
Clickadian™
Indication
Insomnia
Collaborator
Phase
Phase 1: Discovery - CT-111
CT-111
Clickheart™
Indication
Acute Coronary Syndrome
Collaborator
Phase
Phase 1: Discovery
Product
Indication
Collaborator
Phase
Phase 1: Discovery
Phase 2: Dev/Pilot
Phase 3: Pivotal
Regulatory Review
FDA Authorized
Launch
CT-152
Rejoyn
Major Depressive Disorder (MDD)
Launch
Launch- AspyreRx
AspyreRx
AspyreRx™
Type 2 DiabetesFDA Cleared
FDA Cleared - CT-132
CT-132
Episodic MigraineRegulatory Review
Regulatory Review - CT-155
CT-155
Schizophrenia
Phase 3: Pivotal
Phase 3: Pivotal - CT-156
CT-156
SchizophreniaPhase 2: Dev/Pilot
Phase 2: Dev/Pilot - CT-102
CT-102
Opioid Use Disorder (OUD)Phase 2: Dev/Pilot
Phase 2: Dev/Pilot - CT-133
CT-133
Multiple Sclerosis (MS)Phase 1: Discovery
Phase 1: Discovery - CT-171
CT-171
Atopic DermatitisPhase 1: Discovery
Phase 1: Discovery - CT-181
CT-181
ObesityPhase 1: Discovery
Phase 1: Discovery - CT-191
CT-191
OncologyPhase 1: Discovery
Phase 1: Discovery - CT-141
CT-141
Clickadian™
InsomniaPhase 1: Discovery
Phase 1: Discovery - CT-111
CT-111
Clickheart™
Acute Coronary SyndromePhase 1: Discovery
Phase 1: Discovery
Medicine just got a digital upgrade: Software-Enhanced Drugs™
Click SE™ solutions combine software with pharmacotherapy to create software-enhanced drug™ treatments, to deliver added clinical benefit to patients compared to drug alone.
Contact
Q&A